Sign in to view content

Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema

Chirag D. Jhaveri, MD, FASRS

Video
Published 2022

Related

Vision Threatening Complications in Patients With Diabetic Macular Edema: A Post Hoc Analysis of the VISTA and VIVID Trials
Diana V Do, MD, FASRS
Annual Meeting Talks
2019
Efficacy, Safety, and Durability of Faricimab in Diabetic Macular Edema (DME): One-Year Results From the Phase 3 YOSEMITE and RHINE Trials
Caroline Baumal, MD
Annual Meeting Talks
2021
Wet AMD 6 Symposium
Annual Meeting Talks
2020

Category: Diabetic Macular Edema

See more